Transgenic TH-MYCN mice demonstrate a high rate of neuroblastoma tumors that closely resemble human disease, based on their histology, pathology, molecular biology, and location in the paraspinal sympathetic ganglia [187,188]. This evidence concerns the gene MYCN and neuroblastoma.